Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 12/2011

01.12.2011 | Original Paper

Expression and clinical significance of leptin, the functional receptor of leptin (OB-Rb) and HER-2 in non-small-cell lung cancer: a retrospective analysis

verfasst von: Yan-Jie Xu, Yong-Feng Shao, Xia Zhao, Yi-Ting Geng, Kai Wang, Yong-Mei Yin

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 12/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

The human epidermal growth factor receptor 2 (HER-2) and leptin/OB-R system have been reported to be intertwined in several cancer types. However, limited research has been conducted with regard to this interaction in lung cancers. In this study, we investigated the relationship between the expression levels of these proteins and the development, progression and prognosis of non-small-cell lung cancer (NSCLC).

Methods

The expression of leptin, OB-Rb and HER-2 was evaluated in 100 NSCLC specimens by immunohistochemistry, with normal lung tissue as controls. The relationships between their expression levels and clinicopathological factors were evaluated by correlation analysis. Univariate and multivariate analyses were used to determine the associations between the expression levels of these proteins and the survival of NSCLC patients.

Results

Leptin was expressed in 71 and 25% (P < 0.05) of NSCLC and normal lung tissues, respectively, while OB-Rb was expressed in 62 and 31% (P < 0.05), respectively. Overexpression of HER-2 was detected in 53% of NSCLC tissues versus 0% of normal lung tissues (P < 0.05). A significant association was found between the expression levels of leptin and OB-Rb (P = 0.024), and between tumor-node-metastasis (TNM) stage and HER-2 expression (P = 0.003). Univariate survival analysis showed that TNM stage (P < 0.001) and leptin expression (P = 0.009) influenced survival time. Multivariate analysis suggested that TNM stage [hazard ratio (HR) 1.63, 95% confidence interval (CI) 1.30–2.04, P < 0.001] and leptin expression (HR 1.69, 95% CI 1.01–2.80, P = 0.044) were independent prognostic factors for NSCLC.

Conclusions

The expression of leptin, OB-Rb and HER-2 was significantly higher in NSCLC tissues than in normal lung tissues. The expression of leptin is an independent prognostic factor for NSCLC.
Literatur
Zurück zum Zitat Bouloumié A, Drexlerh C, Lafontan M, Busse R (1998) Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 83:1059–1066PubMed Bouloumié A, Drexlerh C, Lafontan M, Busse R (1998) Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 83:1059–1066PubMed
Zurück zum Zitat Catalano S, Marsico S, Giordano C, Mauro L, Rizza P, Panno ML, Andò S (2003) Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. J Biol Chem 278:28668–28676PubMedCrossRef Catalano S, Marsico S, Giordano C, Mauro L, Rizza P, Panno ML, Andò S (2003) Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. J Biol Chem 278:28668–28676PubMedCrossRef
Zurück zum Zitat Cirillo D, Rachiglio AM, la Montagna R, Giordano A, Normanno N (2008) Leptin signaling in breast cancer: an overview. J Cell Biochem 105:956–964PubMedCrossRef Cirillo D, Rachiglio AM, la Montagna R, Giordano A, Normanno N (2008) Leptin signaling in breast cancer: an overview. J Cell Biochem 105:956–964PubMedCrossRef
Zurück zum Zitat Eisenberg A, Biener E, Charlier M, Krishnan RV, Djiane J, Herman B, Gertler A (2004) Transactivation of erbB2 by short and long isoforms of leptin receptors. FEBS Lett 565:139–142PubMedCrossRef Eisenberg A, Biener E, Charlier M, Krishnan RV, Djiane J, Herman B, Gertler A (2004) Transactivation of erbB2 by short and long isoforms of leptin receptors. FEBS Lett 565:139–142PubMedCrossRef
Zurück zum Zitat Fijolek J, Wiatr E, Rowinska-Zakrewska E, Giedronowicz D, Langfort R, Chabowski M, Orłowski T, Roszkowski K (2006) P53 and Her2/neu expression in relation to chemotherapy response in patients with non-small cell lung cancer. Int J Biol Markers 21:81–87PubMed Fijolek J, Wiatr E, Rowinska-Zakrewska E, Giedronowicz D, Langfort R, Chabowski M, Orłowski T, Roszkowski K (2006) P53 and Her2/neu expression in relation to chemotherapy response in patients with non-small cell lung cancer. Int J Biol Markers 21:81–87PubMed
Zurück zum Zitat Fiorio E, Mercanti A, Terrasi M, Micciolo R, Remo A, Auriemma A, Molino A, Parolin V, Di Stefano B, Bonetti F, Giordano A, Cetto GL, Surmacz E (2008) Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis. BMC Cancer 8:305PubMedCrossRef Fiorio E, Mercanti A, Terrasi M, Micciolo R, Remo A, Auriemma A, Molino A, Parolin V, Di Stefano B, Bonetti F, Giordano A, Cetto GL, Surmacz E (2008) Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis. BMC Cancer 8:305PubMedCrossRef
Zurück zum Zitat Frühbeck G (2006) Intracellular signalling pathways activated by leptin. Biochem J 393:7–20PubMedCrossRef Frühbeck G (2006) Intracellular signalling pathways activated by leptin. Biochem J 393:7–20PubMedCrossRef
Zurück zum Zitat Fu XL, Zhu XZ, Shi DR, Xiu LZ, Wang LJ, Zhao S, Qian H, Lu HF, Xiang YB, Jiang GL (1999) Study of prognostic predictors for non-small cell lung cancer. Lung Cancer 23:143–152PubMedCrossRef Fu XL, Zhu XZ, Shi DR, Xiu LZ, Wang LJ, Zhao S, Qian H, Lu HF, Xiang YB, Jiang GL (1999) Study of prognostic predictors for non-small cell lung cancer. Lung Cancer 23:143–152PubMedCrossRef
Zurück zum Zitat Giatromanolaki A, Koukourakis MI, O’Byrne K, Kaklamanis L, Dicoglou C, Trichia E, Whitehouse R, Harris AL, Gatter KC (1996) Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis. Anticancer Res 16:3819–3825PubMed Giatromanolaki A, Koukourakis MI, O’Byrne K, Kaklamanis L, Dicoglou C, Trichia E, Whitehouse R, Harris AL, Gatter KC (1996) Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis. Anticancer Res 16:3819–3825PubMed
Zurück zum Zitat Han H, Landreneau RJ, Santucci TS, Tung MY, Macherey RS, Shackney SE, Sturgis CD, Raab SS, Silverman JF (2002) Prognostic value of immunohistochemical expression of P53, HER2/neu and bcl-2 in stage 1 non-small cell lung cancer. Hum Pathol 33:105–110PubMedCrossRef Han H, Landreneau RJ, Santucci TS, Tung MY, Macherey RS, Shackney SE, Sturgis CD, Raab SS, Silverman JF (2002) Prognostic value of immunohistochemical expression of P53, HER2/neu and bcl-2 in stage 1 non-small cell lung cancer. Hum Pathol 33:105–110PubMedCrossRef
Zurück zum Zitat Hayes DF, Thor AD (2002) C-erbB-2 in breast cancer: development of a clinically useful marker. Semin Oncol 29:231–245PubMedCrossRef Hayes DF, Thor AD (2002) C-erbB-2 in breast cancer: development of a clinically useful marker. Semin Oncol 29:231–245PubMedCrossRef
Zurück zum Zitat Hirsch FR, Franklin WA, Veve R, Varella-Garcia M, Bunn PA Jr (2002) Her2/neu expression in malignant lung tumors. Semin Oncol 29:51–58PubMedCrossRef Hirsch FR, Franklin WA, Veve R, Varella-Garcia M, Bunn PA Jr (2002) Her2/neu expression in malignant lung tumors. Semin Oncol 29:51–58PubMedCrossRef
Zurück zum Zitat Hong SJ, Kwon KW, Kim SG, Ko BM, Ryu CB, Kim YS, Moon JH, Cho JY, Lee JS, Lee MS, Shim CS, Kim BS (2006) Variation in expression of gastric leptin according to differentiation and growth pattern in gastric adenocarcinoma. Cytokine 33:66–71PubMedCrossRef Hong SJ, Kwon KW, Kim SG, Ko BM, Ryu CB, Kim YS, Moon JH, Cho JY, Lee JS, Lee MS, Shim CS, Kim BS (2006) Variation in expression of gastric leptin according to differentiation and growth pattern in gastric adenocarcinoma. Cytokine 33:66–71PubMedCrossRef
Zurück zum Zitat Ishikawa M, Kitayama J, Nagawa H (2004) Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10:4325–4331PubMedCrossRef Ishikawa M, Kitayama J, Nagawa H (2004) Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10:4325–4331PubMedCrossRef
Zurück zum Zitat Janeckova R (2001) The role of leptin in human physiology and pathophysiology. Physiol Res 50:443–459PubMed Janeckova R (2001) The role of leptin in human physiology and pathophysiology. Physiol Res 50:443–459PubMed
Zurück zum Zitat Kern J, Slebos R, Top B, Rodenhuis S, Lager D, Robinson RA, Weiner D, Schwartz DA (1994) C-erbB-2 expression and codon12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. J Clin Invest 93:516–520PubMedCrossRef Kern J, Slebos R, Top B, Rodenhuis S, Lager D, Robinson RA, Weiner D, Schwartz DA (1994) C-erbB-2 expression and codon12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. J Clin Invest 93:516–520PubMedCrossRef
Zurück zum Zitat Kristiansen G, Yu Y, Petersen S, Kaufmann O, Schlüns K, Dietel M, Petersen I (2001) Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer. Eur J Cancer 37:1089–1095PubMedCrossRef Kristiansen G, Yu Y, Petersen S, Kaufmann O, Schlüns K, Dietel M, Petersen I (2001) Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer. Eur J Cancer 37:1089–1095PubMedCrossRef
Zurück zum Zitat Liu L, Shao X, Gao W, Bai J, Wang R, Huang P, Yin Y, Liu P, Shu Y (2010) The role of human epidermal growth factor receptor 2 as a prognostic factor in lung cancer: a meta-analysis of published data. J Thorac Oncol 5:1922–1932PubMedCrossRef Liu L, Shao X, Gao W, Bai J, Wang R, Huang P, Yin Y, Liu P, Shu Y (2010) The role of human epidermal growth factor receptor 2 as a prognostic factor in lung cancer: a meta-analysis of published data. J Thorac Oncol 5:1922–1932PubMedCrossRef
Zurück zum Zitat Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA (2008) Non-small cell lung cancer: epidemiology, risk factors, treatment and survivorship. Mayo Clin Proc 83:584–594PubMedCrossRef Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA (2008) Non-small cell lung cancer: epidemiology, risk factors, treatment and survivorship. Mayo Clin Proc 83:584–594PubMedCrossRef
Zurück zum Zitat Nakamura H, Kawahara N, Taguchi M, Kabasawa K, Association of HER-2 Overexpression with Prognosis in Nonsmall Cell Lung Carcinoma (2005) A metaanalysis. Cancer 103:1865–1873PubMedCrossRef Nakamura H, Kawahara N, Taguchi M, Kabasawa K, Association of HER-2 Overexpression with Prognosis in Nonsmall Cell Lung Carcinoma (2005) A metaanalysis. Cancer 103:1865–1873PubMedCrossRef
Zurück zum Zitat Ogunwobi O, Mutungi G, Beales IL (2006) Leptin stimulates proliferation and inhibits apoptosis in Barrett’s esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2 mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology 147:4505–4516PubMedCrossRef Ogunwobi O, Mutungi G, Beales IL (2006) Leptin stimulates proliferation and inhibits apoptosis in Barrett’s esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2 mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology 147:4505–4516PubMedCrossRef
Zurück zum Zitat Pfeiffer P, Clausen PP, Andersen K, Rose C (1996) Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections. Br J Cancer 74:86–91PubMedCrossRef Pfeiffer P, Clausen PP, Andersen K, Rose C (1996) Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections. Br J Cancer 74:86–91PubMedCrossRef
Zurück zum Zitat Saad RS, Liu Y, Han H, Landreneau RJ, Silverman JF (2004) Prognostic significance of HER2/neu, p53 and vascular endothelial growth factor expression in early stage conventional and bronchioalveolar carcinoma of the lung. Mod Pathol 17:1235–1242PubMedCrossRef Saad RS, Liu Y, Han H, Landreneau RJ, Silverman JF (2004) Prognostic significance of HER2/neu, p53 and vascular endothelial growth factor expression in early stage conventional and bronchioalveolar carcinoma of the lung. Mod Pathol 17:1235–1242PubMedCrossRef
Zurück zum Zitat Scholl S, Beuzeboc P, Pouillart P (2001) Targeting HER-2 in other tumor types. Ann Oncol 12:S81–87PubMedCrossRef Scholl S, Beuzeboc P, Pouillart P (2001) Targeting HER-2 in other tumor types. Ann Oncol 12:S81–87PubMedCrossRef
Zurück zum Zitat Serrano-Olvera A, Dueñas-González A, Gallardo-Rincón D, Candelaria M, De la Garza-Salazar J (2006) Prognostic, predictive and therapeutic implications of HER-2 in invasive epithelial ovarian cancer. Cancer Treat Rev 32:180–190PubMedCrossRef Serrano-Olvera A, Dueñas-González A, Gallardo-Rincón D, Candelaria M, De la Garza-Salazar J (2006) Prognostic, predictive and therapeutic implications of HER-2 in invasive epithelial ovarian cancer. Cancer Treat Rev 32:180–190PubMedCrossRef
Zurück zum Zitat Soma D, Kitayama J, Yamashita H, Miyato H, Ishikawa M, Nagawa H (2007) Leptin augments proliferation of breast cancer cells via transactivation of HER2. J Surg Res 149:9–14PubMedCrossRef Soma D, Kitayama J, Yamashita H, Miyato H, Ishikawa M, Nagawa H (2007) Leptin augments proliferation of breast cancer cells via transactivation of HER2. J Surg Res 149:9–14PubMedCrossRef
Zurück zum Zitat Surmacz E (2007) Obesity hormone leptin: a new target in breast cancer? Breast Cancer Res 9:301PubMed Surmacz E (2007) Obesity hormone leptin: a new target in breast cancer? Breast Cancer Res 9:301PubMed
Zurück zum Zitat Terzidis A, Sergentanis TN, Antonopoulos G, Syrigos C, Efremidis A, Polyzos A, Dessypris N, Petridou ET (2009) Elevated serum leptin levels: a risk factor for non-small-cell lung cancer? Oncol 76:19–25CrossRef Terzidis A, Sergentanis TN, Antonopoulos G, Syrigos C, Efremidis A, Polyzos A, Dessypris N, Petridou ET (2009) Elevated serum leptin levels: a risk factor for non-small-cell lung cancer? Oncol 76:19–25CrossRef
Zurück zum Zitat Zhao L, Shen ZX, Luo HS, Shen L (2005) Possible involvement of leptin and leptin receptor in developing gastric adenocarcinoma. World J Gastroenterol 11:7666–7670PubMed Zhao L, Shen ZX, Luo HS, Shen L (2005) Possible involvement of leptin and leptin receptor in developing gastric adenocarcinoma. World J Gastroenterol 11:7666–7670PubMed
Metadaten
Titel
Expression and clinical significance of leptin, the functional receptor of leptin (OB-Rb) and HER-2 in non-small-cell lung cancer: a retrospective analysis
verfasst von
Yan-Jie Xu
Yong-Feng Shao
Xia Zhao
Yi-Ting Geng
Kai Wang
Yong-Mei Yin
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 12/2011
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-011-1054-5

Weitere Artikel der Ausgabe 12/2011

Journal of Cancer Research and Clinical Oncology 12/2011 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.